Loading...
XTAE
ILX
Market cap185mUSD
Jul 09, Last price  
4,981.00ILS
1D
0.00%
1Q
-13.75%
Jan 2017
11,384.90%
Name

Ilex Medical Ltd

Chart & Performance

D1W1MN
XTAE:ILX chart
P/E
10.03
P/S
0.60
EPS
4.97
Div Yield, %
2.45%
Shrs. gr., 5y
1.00%
Rev. gr., 5y
-0.33%
Revenues
931m
+1.14%
461,424,000432,823,000497,495,000518,943,000553,664,000601,134,000633,958,000946,452,0001,060,994,000872,544,000930,890,000920,371,000930,833,000
Net income
56m
+42.52%
-22,211,00022,103,00031,105,00027,650,00037,403,00046,981,00060,257,000120,621,000197,480,000102,123,00050,885,00038,981,00055,555,000
CFO
73m
-10.73%
22,268,00079,814,00045,175,00012,768,00075,962,00058,601,00084,887,000182,404,000270,676,00069,739,00080,432,00081,630,00072,868,000
Dividend
Apr 07, 2025121.95 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ilex Medical Ltd. engages in medical diagnostics field. It operates through the following segments: Medical Laboratory Equipment and Diagnostics Materials, Medical Equipment, and Inhalation Devices. The Medical Laboratory Equipment and Diagnostics Materials segment deals with the marketing, distribution, and sale of laboratory medical equipment and diagnostics products, diagnostics systems, kits, and consumables for the examination of medical laboratories in hospitals. The Medical Equipment segment handles importation, marketing, and distribution of medical equipment and devices in Israel. The Inhalation Devices segment includes development, manufacture, and marketing of mobile inhalation devices. The company was founded by Moshe Ben Shaul in 1977 and is headquartered in Petach Tikva, Israel.
IPO date
Jan 01, 1995
Employees
255
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT